Gタンパク質結合の終結:GPCR-β-アレスティン複合体の構造のスナップショット
Madhu Chaturvedi1, Jagannath Maharana1, Arun K Shukla1
1Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India.
Cell
|March 15, 2020
まとめ
ベータアレスティンは,Gタンパク質結合受容体 (GPCRs) の主要な調節剤である. 新しい冷凍-EM構造は,βarr1がGPCRとどのように相互作用し,受容体の調節に関する洞察を提供します.
科学分野:
- 生物化学
- 分子生物学
- 構造生物学
背景:
- ベータアレスティンは,Gタンパク質結合受容体 (GPCR) 機能の重要な調節剤である.
- 彼らの役割はGPCRの無感化,内化,シグナル伝達です.
- GPCR-βarrの相互作用を理解することは,細胞の調節を解読するために極めて重要です.
研究 の 目的:
- GPCR-βarrの関与の構造的根拠を解明する.
- GPCR 調節の分子メカニズムを理解するための枠組みを提供すること.
主な方法:
- クリオ電子顕微鏡 (cryo-EM) が使われました.
- 2つの異なるGPCRとβarr1の複合体の構造が決定された.
主要な成果:
- この研究は,GPCR-βarr1複合体に関する最初の構造的洞察を示している.
- これらの構造は,βarr1がGPCRと結合する分子の詳細を明らかにする.
結論:
- 決定された構造は,GPCR-βarrの相互作用を理解するための基本的枠組みを提供します.
- この研究は,GPCRのシグナル伝達と調節に関するさらなる調査の道を開く.
さらに関連する動画
関連する概念動画
Activation and Inactivation of G Proteins
10.4K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
10.4K
G-protein Coupled Receptors
131.2K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.2K
GPCR Desensitization
7.7K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.7K
Assembly of Signaling Complexes
6.4K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.4K
G Protein-coupled Receptors
16.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.1K
Transducer Mechanism: G Protein–Coupled Receptors
3.6K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.6K


